IMMIX BIOPHARMA INC (IMMX) Stock Income Statement
NASDAQ:IMMX - Nasdaq - US45258H1068 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 85.00K | 169.50K | N/A | N/A | N/A | |||
| Operating Expenses | 22.67M | 16.14M | 8.22M | 1.35M | 450.00K | |||
| Research and Development | 11.29M | 8.73M | 4.20M | 130.00K | 250.00K | |||
| Selling, General, and Administrative Expenses | 11.38M | 7.41M | 4.02M | 1.23M | 210.00K | |||
| Operating Income | -22.67M | -16.14M | -8.22M | -1.35M | -450.00K | |||
| Interest Income/Expense | 1.02M | 572.00K | 0.00 | -22.94M | -680.00K | |||
| Other Income/Expense | N/A | 0.00 | N/A | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | 0.00 | -90.00K | N/A | |||
| Income Before Taxes | -21.66M | -15.57M | -8.22M | -24.38M | -1.13M | |||
| Income Tax | 41.00K | 26.40K | 10.00K | 10.00K | 20.00K | |||
| Net Income | -21.61M | -15.43M | -8.23M | -24.38M | -1.15M | |||
| EBITDA | -22.56M | -16.14M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.76 | -0.89 | -0.59 | -3.39 | -0.16 | |||
| Non GAAP EPS | N/A | -0.88 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD